Outcomes of a Specialized Interdisciplinary Approach for Patients with Cancer with Aberrant Opioid‐Related Behavior

Publisher： John Wiley & Sons Inc

E-ISSN： 1549-490x|23|2|263-270

ISSN： 1083-7159

Source： The Oncologist, Vol.23, Iss.2, 2018-02, pp. : 263-270

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gabapentin for opioid-related myoclonus in cancer patients

By Mercadante S.   Villari P.   Fulfaro F.  

Supportive Care in Cancer, Vol. 9, Iss. 3, 2001-05 ,pp. : 205-206

Springer Publishing Company

Access to resources Recommend Favorite

Management of opioid-induced bowel dysfunction in cancer patients

By Tamayo Antonio   Diaz-Zuluaga Paola  

Supportive Care in Cancer, Vol. 12, Iss. 9, 2004-09 ,pp. : 613-618

Springer Publishing Company

Access to resources Recommend Favorite

Health related quality of life assessment methodology and reported outcomes in randomised controlled trials of primary brain cancer patients

By Efficace F.   Bottomley A.  

European Journal of Cancer, Vol. 38, Iss. 14, 2002-09 ,pp. : 1824-1831

Elsevier

Access to resources Recommend Favorite

Presence of Aberrant Tumor-Reactive Immunoglobulins in the Circulation of Patients with Ovarian Cancer

By Gercel-Taylor C.   Bazzett L.B.   Taylor D.D.  

Gynecologic Oncology, Vol. 81, Iss. 1, 2001-04 ,pp. : 71-76

Elsevier

Access to resources Recommend Favorite

Aberrant methylation of CDH11 predicts a poor outcome for patients with bladder cancer

By      

Oncology Letters, Vol. 10, Iss. 2, 2015-01 ,pp. : 647-652

Spandidos Publications

Access to resources Recommend Favorite